All SEC Filings :: Kintara Therapeutics, Inc. (KTRA)

Filing Type:

Year:

Date	Form	Description	Pages
08/28/20	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	8
08/28/20	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	6
08/27/20	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	6
08/25/20	8-K	Current report filing Documents EX-3.1 EX-99.1 EX-99.2	30
08/24/20	8-K/A	Current report filing Documents EX-23.1 EX-99.1 EX-99.2 EX-99.3	40
08/21/20	8-K	Current report filing Documents EX-3.1 EX-3.2 EX-10.4 EX-10.5 EX-99.1 EX-99.2 EX-99.3	76
08/21/20	4	Statement of changes in beneficial ownership of securities	2
08/21/20	4	Statement of changes in beneficial ownership of securities	2
08/21/20	3	Initial statement of beneficial ownership of securities Documents EX-24	2
08/21/20	3	Initial statement of beneficial ownership of securities Documents EX-24	2